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ABSTRACT
Urinary tract infection (UTI) is one of the most prevalent infections in humans. In ≥80% of cases, the etiologic agents are
strains of uropathogenic Escherichia coli (UPEC), which commonly reside in the gastrointestinal tract. Lactobacilli have been
shown to prevent UTI reoccurrence by restoring the urogenital microbiota when administered vaginally or orally. The goal
of this study was to determine if commercial probiotic Lactobacillus spp. reduce or clear UPEC in vitro. Results show that it is
likely that lactobacilli may, in addition to restoring a healthy urogenital microbiota through acidification of their
environment, also displace adhering UPEC and cause a reduction of infection.
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INTRODUCTION
The urinary tract is constantly challenged by microbial invasion
(Ali et al. 2009). This results in urinary tract infection (UTI) being
one of the most prevalent infections in humans. The lifetime
risk for acquiring a symptomatic UTI is about 50% in women
and 12% in men, with a rate of recurrence after six months of
about 40% (Sivick and Mobley 2010). UTI incidence peaks in in-
dividuals in their early 20s and after age 85 (Foxman 1990). If
left untreated, bacteria may ascend the urinary tract and es-
tablish a secondary infection in the kidneys (acute pyelonephri-
tis). In ≥80% of cases, the etiologic agents for UTIs are strains of
uropathogenic Escherichia coli (UPEC), which commonly reside in
the GI tract (Sivick and Mobley 2010). It has been recognized that
UPEC can invade host uroepithelial tissue, contributing signifi-
cantly to the pathogenesis of UTIs by escaping a great number of
antibiotics (Eto, Sundsbak and Mulvey 2006). Internalized UPEC
can persist in quiescence for long periods without causing clin-
ical symptoms (Mulvey, Schilling and Hultgren 2001).
For the treatment and prevention of UPEC-related UTIs in-
cluding recurring infections, the use of low dose once daily or
post-coital antimicrobials have been a cornerstone (Guay 2009).
However, even with urine concentrations of antibiotics far ex-
ceeding minimal inhibitory concentrations, UPEC reservoirs in
tissueswere not eradicated effectively (Blango andMulvey 2010).
Therefore, some alternative non-antimicrobial based therapeu-
tic approaches such as probiotics that may inhibit bacterial ad-
herence and colonization may be of benefit.
The use of probiotics and fermented milk products against
UTI has previously been assessed (Kontiokari et al. 2003). How-
ever, while there is evidence that lactobacilli have an effect on
UTI, their mechanism of action has thus far not been elucidated,
withmost studies relying on circumstantial evidence (Bruce and
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Reid 1988; Saxelin, Pessi and Salminen 1995; Reid and Burton
2002). In all, biosurfactants, bacteriocins, lactic acid and hydro-
gen peroxide from Lactobacillus sp. seem to be inhibitory for UPEC
growth, while adversely affecting fimbrial structure and adhe-
sion and upregulating immunogenicmembrane proteins (Hagan
and Mobley 2007; Cadieux et al. 2009).
The goal of this study was to assess the in vitro antimicro-
bial/bacteriostatic activity of selected commercial Lactobacillus
strains, against UPEC.
MATERIALS AND METHODS
Organisms
Lactobacillus johnsonii strains NCC533 and NCC2917, L. rhamnosus
NCC4007 and L. acidophilus NCC2463, provided by the Nestle´ cul-
ture collection (Nestec Ltd., Lausanne, Switzerland). Uroseptic E.
coli strain CFT073 (O6:K2:H1, ATCC700928) was isolated from the
blood and urine of a woman with acute pyelonephritis (Mobley
et al. 1990). The strain was purchased from the American Type
Culture Collection (LGC Standards, Molsheim Cedex, France).
The UPEC strain UTI89 (O18:K1:H7) was isolated from a patient
with an acute cystitis (Mulvey, Schilling and Hultgren 2001). The
strain was kindly provided by Prof. Urs Jenal from the Biocen-
ter of the University of Basel (Basel, Switzerland). For cell cul-
ture assays, the human bladder cancer cell line UM-UC-3 (ATCC
CRL-1749) was purchased from the American Type Culture Col-
lection (LGC Standards, Molsheim Cedex, France). Bacterial cul-
ture media and components were purchased from Oxoid (Bas-
ingstoke, UK) while cell culture media, cell culture components
and chemicals were purchased from Sigma (Buchs, Switzerland)
unless stated otherwise.
Coculture of UPEC and Lactobacillus spp.
All organisms were grown in fresh LAPT overnight at 37◦C as it
equally supports the growth of Lactobacillus spp. and UPEC. Cul-
tures were diluted to 1 × 108 cfumL−1 in sterile LAPT (1.5% Bacto
Peptone, 1% Bacto Tryptone, 1% yeast extract, 1% glucose and
0.1% Tween 80). Next, 5 × 108 cfu of UPEC and 1 × 108 cfu of Lac-
tobacillus spp. were added to fresh LAPT to give a final volume
of 10 mL. One mL samples of the inocula and 1 mL samples of
coculture were taken after 6 and 24 h to evaluate growth. Sam-
ples were spread in dilutions of 10−1–10−8 on nutrient agar (NA)
and MRS plates and incubated overnight at 37◦C (NA aerobically,
MRS anaerobically) for colony enumeration. To confirm colony
ID, a standard Gram stain of unique colonies on MRS was per-
formed before counting.
Production of Lactobacillus spp. cell-free culture
supernatant
Lactobacillus spp. were grown overnight (37◦C) on De Man-
Rogosa-Sharpe agar (MRS; Difco, Becton Dickinson, Basel,
Switzerland) and then subcultured overnight (37◦C) on modified
MRS broth (mMRS; 1% Peptone #3, 0.5% yeast extract, 0.1%Tween
80, 0.2% [NH4]2C6H6O7, 0.5% CH3COONa, 0.01% MgSO4, 0.005%
MnSO4, 2% K2HPO4 and 60 μM FeSO4–7H2O and 0.5% glucose;
Cadieux et al. 2009). Next, cells were diluted to 1 × 105 cfu mL−1
in 100 mL of fresh mMRS and grown statically for 24 h at 37◦C.
Then, cells were pelleted by centrifugation at 10 000 g (20 min,
4◦C) and the supernatant was collected. For one batch, the su-
pernatant was adjusted to pH 7.0 using 1N NaOH while for an-
other batch, the supernatant was kept at its native pH (4.0–4.4).
Supernatants (cell-free culture supernatants, CFCS) were filter-
sterilized (0.22μm) and fortified using 20% 4×mMRS to avoid the
effect of nutrient depletionwhen used to growUPEC. This fortifi-
cationminimally raised the pHof the supernatants to pH 4.7–5.5.
In order to assess H2O2 production of Lactobacillus spp. and its in-
fluence on UPEC growth, Lactobacillus spp. were grown overnight
(37◦C) on LAPT. Next, cells were diluted to 1 × 105 cfu mL−1 in
100mL of fresh LAPT and grown statically for 24 h at 37◦C. Then,
cells were transferred to a sterile 500 mL culture flask and incu-
bated at 37◦C for 2 h while shaking at 150 rpm. Cells were then
pelleted by centrifugation at 4000 g (10 min, 4◦C), and the super-
natant was collected. The supernatant was pH neutralized us-
ing 1N NaOH, filter-sterilized (0.22 μm) and fortified using 20%
4× LAPT to avoid the effect of nutrient depletion when used to
grow UPEC. Concentrations of H2O2 were measured before ad-
dition of UPEC and after 24 h using a Quantifix Peroxide 25 dip-
stick (Macherey-Nagel, Du¨ren, Germany). All CFCS were stored
at −20◦C until use.
UPEC growth in cell-free culture supernatants
Two hundred thirty micro litres of fortified CFCS was added
to 96-well Greiner flat bottom microtitre plates (Sigma, Buchs,
Switzerland). Overnight cultures (37◦C) of UPEC were diluted to
1× 107 cfumL−1 in PBS (pH 7.0) before 20μL of culturewas added
to the microtitre plates giving a final volume of 250 μL. Optical
density measurements at 600 nm were taken every 15 min for
12 h while incubating at 37◦C on a BMG Labtech Spec-
troStar Omega (BMG LABTECH GmbH Ortenberg, Ger-
many). Prior to each measurement, the plate was shaken
for 10 s.
Acid production by Lactobacillus spp.
Overnight cultures of Lactobacillus spp. were diluted to 1 × 108
cfu mL−1 in sterile LAPT and added to fresh LAPT to give a
final volume of 10 mL. In order to assess the production of
volatile organic acids by Lactobacillus spp., 1 mL aliquots of cul-
ture was taken at inoculation (T0), after 6 h (T6) and after 24 h
(T24) growth at 37◦C and filtered using a 0.22 μm syringe filter.
The filtrate was run on an HPLC Agilent series 1100 HPLC (Agi-
lent, Basel, Switzerland) using a Cation H+ pre-column (BioRad,
Cressier, Switzerland) and Aminex HP×-87H column (BioRad) at
a flow rate of 0.6 ml min−1 (25 min, 35◦C) and an isocratic mobile
phase of 5mMH2SO4. Citric acid, lactic acid, acetic acid, succinic
acid, pyruvic acid, propionic acid and butyric acid were detected
by refractive index and UV (210 nm) spectrometry.
Cell culture adherence–invasion assay
The human bladder cancer cell line UM-UC-3 (ATCC CRL-1749)
was cultured to confluence in 6-well cell culture plates (Corning)
using Dulbecco’s modified Eagle medium supplemented with
10% fetal bovine serum (FBS) at 37◦C and 5% CO2. UPEC and Lac-
tobacillus spp. cultures were grown on NA and MRS overnight
at 37◦C (UPEC aerobically, Lactobacillus spp. anaerobically). UPEC
and Lactobacillus spp. cultures were diluted to 1 × 108 cfu mL−1
in Dulbecco’s modified Eagle medium supplemented with 10%
FBS. Cell cultures were washed 1× with CaCl2 or MgCl2 free PBS
and inoculated with 5 mL of Dulbecco’s modified Eagle medium
supplemented with 10% FBS containing 1 × 108 cfu mL−1 UPEC
and 1 × 108 cfu mL−1 Lactobacillus spp. Plates were centrifuged
at 600 × g for 2.5 min to synchronize the infection process.
One millilitre of the UPEC and Lactobacillus spp. inoculum was
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Figure 1. In vitro cocultures of UPEC and Lactobacillus spp. (L. johnsonii strains NCC533 and NCC2917, L. rhamnosusNCC4007 and L. acidophilusNCC2463) showing influence
of Lactobacillus spp. on (A) growth of E. coli UTI89 and (B) growth of E. coli CFT073, +/− standard deviation (∗P < 0.05, ∗∗P < 0.001, three replicates).
diluted and spread (10−2–10−8) onto NA orMRS, respectively, and
incubated (UPEC aerobically, Lactobacillus spp. anaerobically) at
both 37◦C for 24 h. The infected epithelial cells were incubated
at 37◦Cwith 5%CO2 for 2 h. Tomeasure bacterial adherence, cells
were first washed 4× with PBS to remove non-adherent or non-
invasive microorganisms. Epithelial cells, along with any adher-
ent bacteria, were lifted by incubation in 1× Trypsin-EDTA and
plated (10−2–10−8 dilutions) onto NA and MRS to enumerate ad-
herent UPEC and Lactobacillus spp. Bacterial identities of unique
colony types on each agar (after 24 h, 37◦C incubation) were
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Figure 2. Growth of E. coli UTI89 (A) and E. coli CFT073 (B) on cell-free culture supernatants (CFCS; CFCS at native pH4.7–5.5, CFCS at pH7.0 and CFCS at pH7.0 with
≤2 mM H2O2), LAPT and mMRS (modified MRS) medium, +/− standard deviation (six replicates per group). UPEC growth on CFCS of L. johnsonii strains NCC533 and
NCC2917, L. rhamnosus NCC4007 and L. acidophilus NCC2463 was averaged as no significant difference between groups was observed.
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Table 1. Acid production of commercial probiotic Lactobacillus spp.
(L. johnsonii strains NCC533 and NCC2917, L. acidophilus NCC2463 and
L. rhamnosus NCC4007) is used in this study. Time points at inocula-
tion (T = 0), after 6 h (T = 6) and after 24 h (T = 24) growth at 37◦C.
Succinic Lactic
Sample (gL−1g/l) (gL−1)
NCC 533 T = 0 0.2 0.1
NCC 533 T = 6 0.1 1.8
NCC 533 T = 24 0 6.2
NCC 2917 T = 0 0.2 0
NCC 2917 T = 6 0.1 1.4
NCC 2917 T = 24 0 5.6
NCC 2463 T = 0 0.2 0
NCC 2463 T = 24 0.1 1.3
NCC 2463 T = 6 0.1 4.7
NCC 4007 T = 0 0.2 0
NCC 4007 T = 6 0.1 2.9
NCC 4007 T = 24 0 6.4
LAPT N/A 0.2 0
confirmed as either UPEC or Lactobacillus spp. by Gram strain and
microscopy:
% of adhesive UPEC = Number of invasive cfu
Number of adherent cfu
× 100.
Bacterial invasion was measured using the gentamicin pro-
tection assay (Edwards and Massey 2011). After the 2 h of in-
fection, cells were incubated with 100 μg mL−1 gentamicin for
30 min. Cells were then washed 4× with PBS (without CaCl2
or MgCl2) and lysed using 1 × Trypsin-EDTA including 0.25%
(v/v) Triton ×-100 and plated (10−2–10−8 dilutions) onto NA to
enumerate invasive UPEC. Colonies (after 24 h, 37◦C incubation)
were identified as either UPEC or Lactobacillus spp. by Gram strain
and microscopy:
% of invasive UPEC = Number of invasive cfu
Number of adherent cfu
× 100.
RESULTS AND DISCUSSION
Coculture of UPEC and Lactobacillus spp.
In this study,we assessed the in vitro antimicrobial activity of five
Lactobacillus strains against UPEC. There is evidence that Lacto-
bacillus GR-1 upregulates host antimicrobial factors (Kirjavainen
et al. 2008). However, other factors such as the acidic inhibition
of growth, induction of stress in the outer membrane and mod-
ification of the environment to one that is less conducive to
UPEC thriving seem equally plausible for this and other strains.
In particular, the antimicrobial role of lactic acid produced by
lactobacilli has been controversial in literature with hypothe-
sis ranging from no role at all to lactic acid being an impor-
tant factor (Fayol-Messaoudi et al. 2005; De Keersmaecker et al.
2006; Makras et al. 2006). Previous data suggest that L. johnsonii
NCC533 reduced the viability of UPEC through a combined ac-
tivity of hydrogen peroxide and lactic acid. Plate counts of UPEC
on NA (Fig. 1) showed that after 24 h L. johnsonii NCC533 and L.
rhamnosus NCC4007 significantly reduced UPEC counts to below
inoculum levels. There was a significant reduction of growth of
E. coliUTI89 when comparing counts at 0 and 24 hof coculture as
well as when comparing counts at 6 and 24 h in cocultures con-
taining L. johnsonii NCC533 (P = 0.003 and 0.0001, respectively).
For L. rhamnosus NCC4007, the reduction in counts was only sig-
nificant when comparing 6 and 24 h of culture (P = 0.002). There
also was a significant reduction of growth of E. coli CFT073 when
comparing counts at 0and 24 h of culture as well as when com-
paring counts at 6 and 24 h of culture with L. johnsonii NCC533
(P = 0.004 and 0.0001, respectively). For L. rhamnosus NCC4007,
the reduction in counts was only significant when comparing
6 and 24 h of culture (P = 0.002). In contrast to previous re-
ports, the acidification of the coculture mediummay be the pri-
mary factor that causes this reduction (Atassi and Servin 2010).
For other Lactobacillus species examined here, there was no sig-
nificant effect on either UPEC strain. This may be due to vari-
ous lactobacilli exerting differing activities on UPEC, which war-
rants more detailed characterizations of lactobacilli functions in
the future. Similar has previously been described for lactobacilli
protecting gut barrier functions from enterotoxigenic E. coli
(Liu et al. 2015).
UPEC growth in cell-free culture supernatants
The growth of UTI89 and CFT073 on CFCS was examined spec-
trophotometrically over a period of 12 h at A600nm in order to
assess what cell-free factors may influence a reduction of UPEC
cell counts (Fig. 2). Acidic cell-free culture supernatant (CFCS)
(pH 4.7–5.5) from any Lactobacillus spp. completely inhibited the
growth of both UPEC strains. When the CFCS was neutralized
(pH7.0), bothUPEC strains grewnormally in CFCS of all Lactobacil-
lus spp. even though the exponential phase was slightly shifted
in time. Similar growth was detected in hydrogen peroxide-
containing CFCS. The acidic hydrogen peroxide-free CFCS of L.
johnsonii NCC533, and the other strains tested showed complete
inhibition of UPEC strains CFT073 and UTI89. However, H2O2-
containing CFCS adjusted to pH 7.0 had no effect. Furthermore,
indicator strips for hydrogen peroxide quantification showed
a complete loss of H2O2 (at concentrations produced by lacto-
bacilli) over the time of the assay, presumably due to UPEC cata-
lase activity. Other compounds that may be secreted by either L.
johnsonii NCC533, L. johnsonii NCC2917, L. rhamnosus NCC4007 or
L. acidophilusNCC2463 thatmay act in synergy with lactic acid as
hypothesized by Niku-Paavola et al. (1999) also did not have an
effect, as demonstrated in UPEC cultures with H2O2-free CFCS at
pH7.0.
HPLC analysis of acids showed that lactic acid production in-
creased in Lactobacillus spp. cultures over a 24 h period, rang-
ing from 0 to 0.1 g L−1 at inoculation to 4.7–6.4 g L−1 after 24 h
(Table 1). No other acids were detected in significant amounts.
Besides a reduction of pH, possible mechanisms for the antimi-
crobial activity of lactic acid may be its function as a permeabi-
lizer of Gram-negative bacterial outermembranes and its chelat-
ing properties (Alakomi et al. 2000). Lactic acid may capture iron
which is essential for UPEC growth, causing inhibition (Presser,
Ratkowsky and Ross 1997).
Cell culture adherence–invasion assay
Cell culture of the human bladder cancer cell line UM-UC-3
coinoculated with either UTI89 or CFT073 and Lactobacillus spp.
showed large variations in adhesion and invasion properties
between replicates (Fig. 3). When comparing the% adhesion of
UTI89 to UM-UC-3 cells to the percentage of adhesion of UTI89 to
UM-UC-3 cells when coinoculated with Lactobacillus spp., there
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Figure 3. Percent adhesion (A) and invasion (B) of UTI89 and CFT073 in cell culture using the human bladder cancer cell line UM-UC-3 (ATCC CRL-1749) and Lactobacillus
spp. (L. johnsonii strains NCC533 and NCC2917, L. rhamnosus NCC4007 and L. acidophilus NCC2463), +/− standard deviation (three replicates). Horizontal lines indicate
the level of adhesion / infection of cells associated with UPEC only.
was a general trend of reduced adhesion of UTI89 when coinoc-
ulated with either L. johnsonii NCC533, L. johnsonii NCC2917 or
L. rhamnosus NCC4007 while adhesion tended to increase when
UPEC strains were coincubated with L. acidophilusNCC2463. This
effect is possibly due to L. acidophilus NCC2463 not being able
to displace UPEC from the surface of UM-UC-3 cells. For E. coli
CFT073, a trend for reduction of adhesion was observed for
L. johnsonii NCC533 and L. johnsonii NCC2917 only. In the ab-
sence of Lactobacillus strains, only 2% of adherent E. coli UTI89
were invasive while 17% of adherent E. coli CFT073 were in-
vasive (100% = 1 × 108 cfu mL−1). While there was a general
trend for reduction of invasiveness for both UTI 89 and CFT073
coinoculated with Lactobacillus spp., results did not reach sig-
nificance. An additional mechanism for UPEC inhibition may
be the direct displacement of UPEC adhering to uroepithelial
cells by lactobacilli. This would also cause a reduction in adher-
ence and infection (Velraeds et al. 1999). This possible mecha-
nism was demonstrated in the uro-epithelial cell culture model
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coincubated with UPEC strains CFT073 and UTI89. Here, L. john-
sonii NCC533, L. johnsonii NCC2917 and L. rhamnosus NCC4007 re-
duced the adhesion of both UPEC strains, even though the re-
sults were not significant and assay variation in this study were
too great to make definite assumptions.
CONCLUSION
In conclusion, with increasing rates of antimicrobial resistance
in important pathogens, there is a growing interest in the tar-
geted application of lactobacilli against pathogens. UTI in partic-
ular has been a promising lead for Lactobacillus spp. therapy as it
is mainly caused by one organism, UPEC. While cranberry juice
has been a popular home-remedy, the most promising lead to-
wards the treatment of UTI is the installation of Lactobacillus into
the vagina to form a barrier from infection (Cadieux et al. 2009;
Guay 2009). Lactobacillus rhamnosus GR-1 and L. fermentum RC-14
have been the most promising candidates for this (Reid and
Burton 2002). Commercial probiotic Lactobacillus spp., such as the
ones examined here, may also provide protection from UTI not
necessarily by direct killing of UPEC, but rather through growth
inhibition and direct displacement of UPEC cells. A membrane
permeabilization caused by produced lactic acid as described by
Alakomi et al. (2000) may also be possible. Further in vitro studies
followed by in vivo trials are needed for confirmation.
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